AR024959A1 - A LIQUID PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL - Google Patents

A LIQUID PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL

Info

Publication number
AR024959A1
AR024959A1 ARP000103883A ARP000103883A AR024959A1 AR 024959 A1 AR024959 A1 AR 024959A1 AR P000103883 A ARP000103883 A AR P000103883A AR P000103883 A ARP000103883 A AR P000103883A AR 024959 A1 AR024959 A1 AR 024959A1
Authority
AR
Argentina
Prior art keywords
paracetamol
liquid pharmaceutical
pharmaceutical composition
composition based
solution
Prior art date
Application number
ARP000103883A
Other languages
Spanish (es)
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of AR024959A1 publication Critical patent/AR024959A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una forma de dosificacion farmacéutica líquida que consiste en una solucion, la cual comprende por lo menos el 10% (p/v) de paracetamol en PEG-200 anhidro.A liquid pharmaceutical dosage form consisting of a solution, which comprises at least 10% (w / v) paracetamol in anhydrous PEG-200.

ARP000103883A 1999-07-30 2000-07-27 A LIQUID PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL AR024959A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001697A IT1313579B1 (en) 1999-07-30 1999-07-30 PARACETAMOL-BASED LIQUID PHARMACEUTICAL COMPOSITION.

Publications (1)

Publication Number Publication Date
AR024959A1 true AR024959A1 (en) 2002-10-30

Family

ID=11383451

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103883A AR024959A1 (en) 1999-07-30 2000-07-27 A LIQUID PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL

Country Status (4)

Country Link
AR (1) AR024959A1 (en)
AU (1) AU6565100A (en)
IT (1) IT1313579B1 (en)
WO (1) WO2001008662A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862872A1 (en) * 2003-12-02 2005-06-03 Palbian Snc AQUEOUS COMPOSITION FOR THE PERFUSABLE APPLICATION OF AN ACTIVE, PARTICULARLY PHARMACOLOGICAL PRINCIPLE SUCH AS PARACETAMOL
US9585849B2 (en) 2006-04-17 2017-03-07 The Burlington Hc Research Group, Inc. Broad spectrum antiviral and methods of use
EP1992334A1 (en) * 2007-05-08 2008-11-19 Docpharma NV/SA Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation
US20110098359A1 (en) 2007-08-07 2011-04-28 Stellenbosch University Compositions and Methods for Treatment of Glaucoma
EP2243477A1 (en) * 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol for parenteral application
ES2866636T3 (en) * 2010-06-30 2021-10-19 Troikaa Pharmaceuticals Ltd Pharmaceutical compositions comprising paracetamol and process for preparing the same
IT1403660B1 (en) * 2011-01-28 2013-10-31 Abiogen Pharma Spa PHARMACEUTICAL COMPOSITION LIQUID CONTAINING PARACETAMOL
CA2919892C (en) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US20150141518A1 (en) * 2013-11-21 2015-05-21 Emphascience, Inc. Water-miscible stable solution composition for pharmaceutically active ingredients that are poorly soluble in water and susceptible to chemical degradation
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9707184B2 (en) 2014-07-17 2017-07-18 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US20160144033A1 (en) * 2014-11-21 2016-05-26 Emphascience, Inc. Concentrated acetaminophen solution
EP3233055A1 (en) 2014-12-20 2017-10-25 Troikaa Pharmaceuticals Ltd Injectable formulations of paracetamol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5505961A (en) * 1993-08-05 1996-04-09 R. P. Scherer Corporation Gelatin capsules containing a highly concentrated acetaminophen solution
US5510389A (en) * 1994-03-02 1996-04-23 The Procter & Gamble Company Concentrated acetaminophen solution compositions
FR2751875B1 (en) * 1996-08-05 1998-12-24 Scr Newpharm NOVEL STABLE LIQUID FORMULATIONS BASED ON PARACETAMOL AND THEIR METHOD OF PREPARATION

Also Published As

Publication number Publication date
ITMI991697A0 (en) 1999-07-30
WO2001008662A1 (en) 2001-02-08
ITMI991697A1 (en) 2001-01-30
IT1313579B1 (en) 2002-09-09
AU6565100A (en) 2001-02-19

Similar Documents

Publication Publication Date Title
AR024959A1 (en) A LIQUID PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL
PT1318791E (en) ISOTRETINOIN SEMI-SOLID PHARMACEUTICAL COMPOSITION
RS54275B1 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
CO5580776A2 (en) STABLE PHARMACEUTICAL FORMULATION IN SOLUTION OF OXALIPLATIN
PA8509001A1 (en) DOSAGE FORM OF DRUGS DRIVEN BY A HYDROGEL
AR033423A1 (en) PHARMACEUTICAL SALTS CONSTITUTED OF AN ACTIVE PHARMACEUTICAL SUBSTANCE AND AT LEAST A SWEETENER, MEDICATIONS CONTAINING THESE SALTS AND USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES
DE60019693D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE ABSORPTION-CONNECTING COMPOUNDS
HK1080364A1 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
PA8508701A1 (en) PHARMACEUTICAL COMPOSITIONS THAT PROVIDE POWERFUL FARMACO CONCENTRATIONS
DE69927803D1 (en) IMIDAZO-PYRIDINE COMPOUNDS THAT PREVENT THE SECRETION OF MAGIC ACID.
MXPA02007915A (en) Aspirin triggered lipid mediators.
DE60134245D1 (en) (5- (2-HYDROXY-4-CHLOROBENZOYL) VALERIANIC ACID AND ITS SALTS, AND COMPOSITIONS FOR ADDING ACTIVITIES CONTAINING THESE COMPOUNDS
AR028727A1 (en) A LIQUID DETERGENT COMPOSITION
DE69907926D1 (en) 1,2,4-TRIAZOL-3-THION COMPOUNDS
BR0013106A (en) Floating pharmaceutical composition, tablet, and tablet preparation process.
CO5570681A2 (en) RIBAVIRINA SYRUP FORMULATIONS
CO4950520A1 (en) PARENTERAL FORMULATIONS OF 5H-DIBENZ (B, F) AZEPIN-5- CARBOXIAMIDES USEFUL IN THE TREATMENT OF EPILEPTIC ATTACKS
ES2173556T3 (en) NEW HETEROCICLIC COMPOUNDS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOUNDS THAT CONTAIN THEM.
ATE338567T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING ACTIVE INGREDIENTS SUITABLE FOR UNAUTHORIZED ADMINISTRATION
SE9902742D0 (en) New pharmaceutical formultion
DE59510583D1 (en) PHARMACEUTICAL COMPOSITION FOR SYSTEMIC TRANSDERMAL ADMINISTRATION WITH THE ACTIVE MORPHINE-6-GLUCURONIDE
ATE263547T1 (en) PHARMACEUTICAL MIXTURE CONTAINING A PROFENE AND OTHER ACTIVE SUBSTANCES
IT1265647B1 (en) TOPICAL PHARMACEUTICAL COMPOSITION FOR RESPIRATORY ALLERGIES
EA200400382A1 (en) APPLICATION OF SPECIFIC DOSE OF SODIUM FONDAPARINUKS FOR THE TREATMENT OF OX
ATE227997T1 (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION OF THIOCOLCHICOSIDE